6.
Surti U, Hoffner L, Chakravarti A, Ferrell R
. Genetics and biology of human ovarian teratomas. I. Cytogenetic analysis and mechanism of origin. Am J Hum Genet. 1990; 47(4):635-43.
PMC: 1683780.
View
7.
Linder D
. Gene loss in human teratomas. Proc Natl Acad Sci U S A. 1969; 63(3):699-704.
PMC: 223508.
DOI: 10.1073/pnas.63.3.699.
View
8.
Chang H, Qiao J, Leung P
. Oocyte-somatic cell interactions in the human ovary-novel role of bone morphogenetic proteins and growth differentiation factors. Hum Reprod Update. 2016; 23(1):1-18.
PMC: 5155571.
DOI: 10.1093/humupd/dmw039.
View
9.
Mayer A, Fouquet B, Pugeat M, Misrahi M
. BMP15 "knockout-like" effect in familial premature ovarian insufficiency with persistent ovarian reserve. Clin Genet. 2017; 92(2):208-212.
DOI: 10.1111/cge.12970.
View
10.
Dong J, Albertini D, Nishimori K, Kumar T, Lu N, Matzuk M
. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature. 1996; 383(6600):531-5.
DOI: 10.1038/383531a0.
View
11.
Abir R, Ben-Haroush A, Melamed N, Felz C, Krissi H, Fisch B
. Expression of bone morphogenetic proteins 4 and 7 and their receptors IA, IB, and II in human ovaries from fetuses and adults. Fertil Steril. 2007; 89(5 Suppl):1430-40.
DOI: 10.1016/j.fertnstert.2007.04.064.
View
12.
Heskett M, Sanborn J, Boniface C, Goode B, Chapman J, Garg K
. Multiregion exome sequencing of ovarian immature teratomas reveals 2N near-diploid genomes, paucity of somatic mutations, and extensive allelic imbalances shared across mature, immature, and disseminated components. Mod Pathol. 2020; 33(6):1193-1206.
PMC: 7286805.
DOI: 10.1038/s41379-019-0446-y.
View
13.
Kristensen S, Kumar A, Mamsen L, Kalra B, Pors S, Botkjaer J
. Intrafollicular Concentrations of the Oocyte-secreted Factors GDF9 and BMP15 Vary Inversely in Polycystic Ovaries. J Clin Endocrinol Metab. 2022; 107(8):e3374-e3383.
PMC: 9282257.
DOI: 10.1210/clinem/dgac272.
View
14.
Taylor-Weiner A, Zack T, ODonnell E, Guerriero J, Bernard B, Reddy A
. Genomic evolution and chemoresistance in germ-cell tumours. Nature. 2016; 540(7631):114-118.
PMC: 5553306.
DOI: 10.1038/nature20596.
View
15.
Shimasaki S, Moore R, Otsuka F, Erickson G
. The bone morphogenetic protein system in mammalian reproduction. Endocr Rev. 2004; 25(1):72-101.
DOI: 10.1210/er.2003-0007.
View
16.
Fabre S, Pierre A, Mulsant P, Bodin L, Di Pasquale E, Persani L
. Regulation of ovulation rate in mammals: contribution of sheep genetic models. Reprod Biol Endocrinol. 2006; 4:20.
PMC: 1524776.
DOI: 10.1186/1477-7827-4-20.
View
17.
Belli M, Shimasaki S
. Molecular Aspects and Clinical Relevance of GDF9 and BMP15 in Ovarian Function. Vitam Horm. 2018; 107:317-348.
PMC: 6309678.
DOI: 10.1016/bs.vh.2017.12.003.
View
18.
Hashimoto N, Watanabe N, Furuta Y, Tamemoto H, Sagata N, Yokoyama M
. Parthenogenetic activation of oocytes in c-mos-deficient mice. Nature. 1994; 370(6484):68-71.
DOI: 10.1038/370068a0.
View
19.
Bouilly J, Beau I, Barraud S, Bernard V, Azibi K, Fagart J
. Identification of Multiple Gene Mutations Accounts for a new Genetic Architecture of Primary Ovarian Insufficiency. J Clin Endocrinol Metab. 2016; 101(12):4541-4550.
DOI: 10.1210/jc.2016-2152.
View
20.
Riley P, Sutton P
. Ovarian teratomas and genetics of germ-cell formation. Lancet. 1977; 1(8007):362-3.
DOI: 10.1016/s0140-6736(77)91161-8.
View